 CAMBRIDGE, Mass., July 14, 2021 GLOBE NEWSWIRE -- Evelo Biosciences, Inc. Nasdaq: EVLO, a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced that on July 12, 2021, Ayse Kocak commenced her services as Evelos Head of International Special Projects. 